Oramed Pharmaceuticals, Inc. (ORMP)
3.27
+0.10
(+3.15%)
USD |
NASDAQ |
Feb 13, 14:21
Oramed Pharmaceuticals Free Cash Flow : -11.03M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lifeward Ltd. | -17.24M |
| Bristol Myers Squibb Co. | 12.84B |
| Instil Bio, Inc. | -40.10M |
| Nektar Therapeutics | -190.35M |
| Innoviva, Inc. | 196.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.987M |
| Cash from Investing (Quarterly) | 38.84M |
| Cash from Financing (Quarterly) | -0.3926M |
| Free Cash Flow Per Share (Quarterly) | -0.0465 |
| Free Cash Flow to Equity (Quarterly) | -1.935M |
| Free Cash Flow to Firm (Quarterly) | -1.987M |
| Free Cash Flow Yield | -8.10% |